Home Cart Sign in  
Chemical Structure| 28053-08-9 Chemical Structure| 28053-08-9

Structure of 28053-08-9

Chemical Structure| 28053-08-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR.

Synonyms: UDP-D-Glucose disodium salt; UDPG; UYD77NZ2JQ

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Uridine 5′-diphosphoglucose disodium salt

CAS No. :28053-08-9
Formula : C15H22N2Na2O17P2
M.W : 610.27
SMILES Code : O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]([C@H]1O)O)OP([O-])(OP([O-])(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)N3C=CC(NC3=O)=O)=O)=O.[Na+].[Na+]
Synonyms :
UDP-D-Glucose disodium salt; UDPG; UYD77NZ2JQ

Safety of Uridine 5′-diphosphoglucose disodium salt

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Uridine 5′-diphosphoglucose disodium salt

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RBL-2H3 mast cells 10 µM 1-60 minutes To investigate the effect of UDPG on MAPK activation. Results showed that UDPG induced phosphorylation of ERK1/2, P38, and JNK, and ERK1/2 activation was PTX-sensitive. Biochem Pharmacol. 2010 Mar 15;79(6):873-9
COS-7 cells 0.35 ± 0.12 µM 20 minutes To evaluate the agonist activity of UDPG at the P2Y14 receptor, showing an EC50 of 0.35 ± 0.12 µM. J Med Chem. 2007 May 3;50(9):2030-9
RBL-2H3 mast cells 1150 ± 320 nM (EC50) 20 minutes To investigate the role of UDPG in mediating mast cell degranulation via P2Y14 receptor. Results showed that UDPG and its analog MRS2690 enhanced antigen-induced HEX release in a concentration-dependent manner, and this effect was blocked by pertussis toxin and P2Y14 receptor-specific siRNA. Biochem Pharmacol. 2010 Mar 15;79(6):873-9
Rat cortical neurons 100 µM 24 hours To evaluate the effect of UDP-G on neuronal apoptosis, results showed UDP-G decreased cell viability, increased apoptotic marker CC3 levels and TUNEL positive neurons Stroke. 2024 May;55(5):1381-1392
INS-1 832/13 cells 10 µM 24 hours To investigate the effect of UDP-G on cell proliferation, results showed that UDP-G suppressed cell proliferation under high glucose conditions. J Biol Chem. 2020 Nov 6;295(45):15245-15252
INS-1 832/13 cells 10 µM 60 minutes To investigate the effect of UDP-G on GSIS, results showed that UDP-G suppressed GSIS and was associated with suppression of cAMP. J Biol Chem. 2020 Nov 6;295(45):15245-15252
Human pancreatic islets 10 µM 60 minutes To investigate the effect of UDP-G on glucose-stimulated insulin secretion (GSIS), results showed that UDP-G dose-dependently suppressed GSIS. J Biol Chem. 2020 Nov 6;295(45):15245-15252
INS-1 832/13 cells 10 µM 72 hours To investigate the effect of UDP-G on apoptosis, results showed that UDP-G increased apoptosis under high glucose conditions. J Biol Chem. 2020 Nov 6;295(45):15245-15252
Human pancreatic islets 10 µM 72 hours To investigate the effect of UDP-G on islet cell reductive capacity, results showed that UDP-G decreased the reductive capacity of islets. J Biol Chem. 2020 Nov 6;295(45):15245-15252

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Subarachnoid hemorrhage model Intranasal administration 7.1 mg/kg Administered at 1h after SAH, short-term study at 24h, long-term study at 28 days To evaluate the role of UDP-G/P2Y14 signaling in SAH, results showed PPTN improved neurological function and reduced neuronal apoptosis, while UDP-G exacerbated these outcomes Stroke. 2024 May;55(5):1381-1392

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.19mL

1.64mL

0.82mL

16.39mL

3.28mL

1.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories